← 返回產品資料庫

羅氏人類上皮因子接受體第二蛋白兔子單株一級抗體

🩺 醫材

Roche PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody

衛署醫器輸字第020367號

醫材分類

3 等級
  • B.1860免疫病理組織化學試劑與套組

醫器規格

# 790-2991:50 tests

限制項目

輸 入

適應症

供實驗室用以在Ventana自動免疫組織化學切片染色機上半定量檢測經福馬林固定、石蠟包埋的正常及腫瘤組織內的HER2抗原,對於考慮以賀癌平(Herceptin)治療的乳癌病患之評估,此一級抗體可作為一個輔助工具之用。

醫材資訊

主成分
PATHWAY anti-HER-2/neu (4B5) Primary Antibody contains sufficient reagent for 50 tests.\n1-5 ml dispenser PATHWAY anti-HER-2/neu (4B5) Primary Antibody contains approximately 30 ug of a rabbit monoclonal antibody directed against human c-erbB-2 antigen. The antibody is diluted in 0.05 M Tris buffered saline, 0.01 M EDTA, 0.05% Brij-35 with 0.3% carrier protein and 0.05% sodium azide, a preservative. There is trace fetal calf serum, approximately 0.25%, present from the stock solution. Total protein concentration of the reagent is approximately 16 mg/ml. Specific antibody concentration is approximately 6 ug/ml. PATHWAY anti-HER-2/neu (4B5) Primary Antibody is a rabbit lgG diluted from tissue culture supernatants. There is no known irrelevant antibody reactivity observed in this product.
製造商
VENTANA MEDICAL SYSTEMS, INC
製造國
US
申請商
台灣羅氏醫療診斷設備股份有限公司
有效日期
2029/08/25
發證日期
2009/08/25

供應藥局

目前尚無登錄供應此品項的藥局資料。